Rogel Cancer Center: University of Michigan
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 1991-01-01
- Employees
- -
- Market Cap
- -
Pre-operative Chemotherapy and Radiation Therapy for Esophageal Carcinoma
Phase 2
Completed
- Conditions
- Esophageal Cancer
- First Posted Date
- 2005-09-30
- Last Posted Date
- 2010-01-15
- Lead Sponsor
- University of Michigan Rogel Cancer Center
- Registration Number
- NCT00230451
- Locations
- 🇺🇸
University of Michigan Cancer Center, Ann Arbor, Michigan, United States
Combination Chemotherapy Treatments in Patients With Metastatic Colorectal Cancer
Phase 2
Completed
- Conditions
- Colorectal Cancer
- First Posted Date
- 2005-09-30
- Last Posted Date
- 2015-04-21
- Lead Sponsor
- University of Michigan Rogel Cancer Center
- Target Recruit Count
- 15
- Registration Number
- NCT00230399
- Locations
- 🇺🇸
University of Michigan Cancer Center, Ann Arbor, Michigan, United States
Evaluation of Side Effects and Relative Activity of Two Chemotherapy Regimens in the Treatment Soft Tissue Sarcoma
Phase 2
Completed
- Conditions
- Sarcoma, Soft Tissue
- Interventions
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2015-12-07
- Lead Sponsor
- University of Michigan Rogel Cancer Center
- Target Recruit Count
- 84
- Registration Number
- NCT00189137
- Locations
- 🇺🇸
University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States
Irinotecan, 5-Fluorouracil, and Leucovorin in Colorectal Carcinoma
Phase 2
Completed
- Conditions
- Colorectal Carcinoma
- First Posted Date
- 2005-09-15
- Last Posted Date
- 2012-02-07
- Lead Sponsor
- University of Michigan Rogel Cancer Center
- Target Recruit Count
- 24
- Registration Number
- NCT00176774
- Locations
- 🇺🇸
University of Michigan Cancer Center, Ann Arbor, Michigan, United States
Treatment for Patients With Metastatic Thyroid Cancer
- First Posted Date
- 2005-09-15
- Last Posted Date
- 2010-01-15
- Lead Sponsor
- University of Michigan Rogel Cancer Center
- Target Recruit Count
- 3
- Registration Number
- NCT00176748
- Locations
- 🇺🇸
University of Michigan Cancer Center, Ann Arbor, Michigan, United States
Chemoradiation and Tetrathiomolybdate (TM) in Patients With Esophageal Carcinoma
Phase 2
Completed
- Conditions
- Esophageal Carcinoma
- Interventions
- First Posted Date
- 2005-09-15
- Last Posted Date
- 2016-08-22
- Lead Sponsor
- University of Michigan Rogel Cancer Center
- Target Recruit Count
- 69
- Registration Number
- NCT00176800
- Locations
- 🇺🇸
University of Michigan Cancer Center, Ann Arbor, Michigan, United States
Capecitabine and Radiation Therapy in Advanced Pancreatic Cancer
Not Applicable
Terminated
- Conditions
- Pancreatic Cancer
- First Posted Date
- 2005-09-15
- Last Posted Date
- 2015-05-20
- Lead Sponsor
- University of Michigan Rogel Cancer Center
- Registration Number
- NCT00176735
Radiation Therapy With Capecitabine in Rectal Cancer
Phase 2
Terminated
- Conditions
- Rectal Cancer
- First Posted Date
- 2005-09-15
- Last Posted Date
- 2008-01-10
- Lead Sponsor
- University of Michigan Rogel Cancer Center
- Target Recruit Count
- 30
- Registration Number
- NCT00176787
- Locations
- 🇺🇸
University of Michigan Cancer Center, Ann Arbor, Michigan, United States
Tumor-Pulsed Dendritic Cells Used as a Tumor Vaccine
Phase 2
Terminated
- Conditions
- Metastatic Colorectal Cancer
- First Posted Date
- 2005-09-15
- Last Posted Date
- 2006-09-11
- Lead Sponsor
- University of Michigan Rogel Cancer Center
- Target Recruit Count
- 27
- Registration Number
- NCT00176761
- Locations
- 🇺🇸
University of Michigan Cancer Center, Ann Arbor, Michigan, United States
Gemcitabine, Cisplatin, and Celecoxib Treatment of Metastatic Pancreatic Cancer
Phase 2
Completed
- Conditions
- Pancreatic Cancer
- First Posted Date
- 2005-09-15
- Last Posted Date
- 2008-05-06
- Lead Sponsor
- University of Michigan Rogel Cancer Center
- Target Recruit Count
- 5
- Registration Number
- NCT00176813
- Locations
- 🇺🇸
University of Michigan, Ann Arbor, Michigan, United States
© Copyright 2025. All Rights Reserved by MedPath